RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Respiratory Tract Infections |
|
Accession: | DOID:9008680
|
browse the term
|
Definition: | Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. |
Synonyms: | exact_synonym: | Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections |
| primary_id: | MESH:D012141; RDO:0000329 |
|
|
|
G |
BDNF |
brain derived neurotrophic factor |
|
ISO |
protein:decreased expression:platelet, serum |
RGD |
PMID:17317133 |
RGD:4891069 |
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:19039768 |
RGD:4892119 |
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
|
|
G |
FBLN5 |
fibulin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12189163 |
|
NCBI chr 7:113,423,629...113,526,412
Ensembl chr 7:113,423,632...113,512,198
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
Severe Acute Respiratory Syndrome |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL16 |
interleukin 16 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 7:49,973,937...50,102,346
Ensembl chr 7:49,973,938...50,102,346
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma |
RGD |
PMID:20573437 |
RGD:5128554 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
IL6R |
interleukin 6 receptor |
|
ISO |
DNA:polymorphisms:promoter, exon:-183G>A (human) |
RGD |
PMID:20951753 |
RGD:5128631 |
NCBI chr 4:95,322,426...95,381,393
Ensembl chr 4:95,322,433...95,381,282
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:10497103 |
RGD:5128721 |
NCBI chr 2:134,776,122...134,783,646
Ensembl chr 2:134,776,129...134,783,801
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:17027894 |
RGD:5128795 |
NCBI chr 6:54,701,733...54,706,079
Ensembl chr 6:54,701,668...54,707,151
|
|
G |
LEPR |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17229951 |
|
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) DNA:polymorphisms:5' utr, exon:multiple (human) protein:decreased secretion:serum (human) |
RGD |
PMID:15249448 PMID:19169708 PMID:19767106 |
RGD:4889439 RGD:4889453 RGD:8693755 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
ISO |
protein:increased expression:blood (human) |
RGD |
PMID:25542463 |
RGD:126777677 |
NCBI chr13:204,843,049...204,868,927
Ensembl chr13:204,843,754...204,868,922
|
|
G |
RPGR |
retinitis pigmentosa GTPase regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12920075 |
|
NCBI chr X:34,238,961...34,522,814
Ensembl chr X:34,228,124...34,296,589
|
|
G |
SLA-8 |
MHC class I antigen 8 |
|
ISO |
|
RGD |
PMID:19775370 |
RGD:5144114 |
NCBI chr 7:23,622,352...23,625,818
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
Severe Acute Respiratory Syndrome; protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chr 6:19,345,929...19,372,972
Ensembl chr 6:19,345,941...19,348,926
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:15951834 |
RGD:5688155 |
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
|
|
G |
CFTR |
CF transmembrane conductance regulator |
|
ISO |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chr18:28,627,717...28,818,209
Ensembl chr18:28,627,728...28,817,950
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577 RGD:8693711 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
TLR9 |
toll like receptor 9 |
susceptibility |
ISO |
DNA:SNP:promoter:g.-1237T>C (rs5743836) (human) |
RGD |
PMID:18275280 PMID:18936185 |
RGD:5130858 RGD:5130863 |
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
|
|
|
G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
severity |
ISO |
DNA:snp:exon:c.1236C>T (human) |
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chr 9:93,049,955...93,146,469
|
|
G |
ACE |
angiotensin I converting enzyme |
no_association |
ISO |
DNA:deletion:intron:IVS16+1464-1751del (human) |
RGD |
PMID:15112973 |
RGD:8142345 |
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (rat) |
RGD |
PMID:15362690 |
RGD:11522724 |
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
|
|
G |
CAT |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29028686 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CCL11 |
chemokine (C-C motif) ligand 11 |
treatment |
ISO |
|
RGD |
PMID:23089405 |
RGD:7248414 |
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
|
|
G |
CCL26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:oronasal secretion (human) |
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chr 3:10,381,306...10,385,677
Ensembl chr 3:10,381,306...10,385,677
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
|
|
G |
CLDN3 |
claudin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr 3:11,019,073...11,020,102
Ensembl chr 3:11,019,073...11,020,102
|
|
G |
CLDN7 |
claudin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr12:52,612,517...52,628,376
Ensembl chr12:52,612,510...52,628,362
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:21711961 |
RGD:5147783 |
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
|
|
G |
FCGR3A |
Fc fragment of IgG receptor IIIa |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chr 4:88,948,357...88,956,513
|
|
G |
GRIA1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr16:69,332,786...69,654,366
Ensembl chr16:69,332,587...69,655,380
|
|
G |
GRIA2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 8:46,078,122...46,247,144
Ensembl chr 8:46,078,276...46,241,914
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
|
|
G |
HRH1 |
histamine receptor H1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23333628 |
|
NCBI chr13:67,209,261...67,411,174
Ensembl chr13:67,209,127...67,411,170
|
|
G |
IFNG |
interferon gamma |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism associated with Asthma |
RGD CTD |
PMID:12787306 PMID:18510219 PMID:29871060 |
RGD:10755770 RGD:7829803 |
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23253209 PMID:23883806 PMID:36127783 |
RGD:7364793 RGD:7364818 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL13 |
interleukin 13 |
susceptibility no_association |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) |
OMIM CTD RGD |
PMID:12928861 |
RGD:8549516 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chr X:94,402,665...94,455,609
Ensembl chr X:94,402,676...94,439,060
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
ISO |
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21535180 PMID:22507625 |
RGD:5147409 RGD:9068429 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL18 |
interleukin 18 |
severity no_association |
ISO |
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human) |
RGD |
PMID:22840759 |
RGD:8655914 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8908280 PMID:9893928 PMID:14653048 PMID:24620662 PMID:36127783 |
RGD:11522769 RGD:7829796 RGD:7829802 RGD:7829827 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
IL5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976 RGD:11522769 |
NCBI chr 2:134,832,143...134,846,141
Ensembl chr 2:134,832,147...134,835,212
|
|
G |
ITGB2 |
integrin subunit beta 2 |
treatment |
ISO |
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chr13:207,514,281...207,544,108
Ensembl chr13:207,512,950...207,544,107
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7750009 |
RGD:7401199 |
|
|
G |
MRC1 |
mannose receptor C-type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr10:44,107,926...44,226,734
Ensembl chr10:44,107,072...44,226,733
|
|
G |
MUC1 |
mucin 1, cell surface associated |
severity |
ISO |
mRNA,protein:decreased expression:nasal mucosa |
RGD |
PMID:31425778 |
RGD:127345100 |
NCBI chr 4:94,626,317...94,631,194
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium |
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chr 2:757,897...790,321
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:23858718 |
RGD:8547523 |
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
|
|
G |
OCLN |
occludin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,212...47,654,033
|
|
G |
PON1 |
paraoxonase 1 |
severity |
ISO |
protein:decreased activity:plasma (human) |
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chr 9:74,943,646...74,974,720
Ensembl chr 9:74,926,048...74,974,723
|
|
G |
PRKG1 |
protein kinase cGMP-dependent 1 |
|
ISO |
protein:increased expression:nasal cavity epithelium |
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chr14:97,558,531...98,793,080
Ensembl chr14:97,558,533...98,793,010
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16979129 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
mRNA:decreased expression:nasal mucosa, lung |
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chr 2:9,297,282...9,302,204
Ensembl chr 2:9,297,283...9,302,165
|
|
G |
SCGB3A2 |
secretoglobin family 3A member 2 |
susceptibility |
ISO |
DNA:SNP: :rs7726552 (human) |
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chr 2:149,120,652...149,124,614
Ensembl chr 2:149,068,946...149,124,983
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
mRNA:increased expression:nasal mucosa (mouse) |
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
|
|
G |
SLA-8 |
MHC class I antigen 8 |
|
ISO |
|
RGD |
PMID:20487636 |
RGD:5144132 |
NCBI chr 7:23,622,352...23,625,818
|
|
G |
TACR1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:nasal mucosa |
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chr 3:67,839,367...68,021,733
Ensembl chr 3:67,839,411...68,021,724
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
|
|
G |
TLR2 |
toll like receptor 2 |
severity |
ISO |
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa: |
RGD |
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057 |
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
G |
TLR4 |
toll like receptor 4 |
no_association treatment susceptibility severity |
ISO |
protein:increased expression:nasal lavage,leukocyte, bone marrow: DNA:polymorphism: :4216G>C(human) DNA:SNP: :rs1927911(human) protein:decreased expression:nasal mucosa: DNA:polymorphism:cds:p.D299G(human) |
RGD |
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
|
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993 |
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
|
|
G |
TLR9 |
toll like receptor 9 |
|
ISO |
protein:decreased expression:nasal mucosa: |
RGD |
PMID:22577387 |
RGD:7800740 |
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
|
|
|
G |
CYP2C49 |
cytochrome P450 2C49 |
treatment |
ISO |
associated with Eosinophilic Esophagitis; DNA:polymorphisms:: |
RGD |
PMID:26416193 |
RGD:11352743 |
NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr10:32,110,366...32,112,529
Ensembl chr10:32,110,065...32,112,734
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr12:21,857,286...21,869,211
Ensembl chr12:21,857,286...21,872,475
|
|
G |
CD209 |
CD209 molecule |
|
ISO |
|
RGD |
PMID:21381282 |
RGD:5131183 |
NCBI chr 2:71,394,414...71,397,711
Ensembl chr 2:71,394,391...71,397,968
|
|
G |
CFTR |
CF transmembrane conductance regulator |
severity |
ISO |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chr18:28,627,717...28,818,209
Ensembl chr18:28,627,728...28,817,950
|
|
G |
CLEC1A |
C-type lectin domain family 1 member A |
susceptibility |
ISO |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to |
OMIM ClinVar |
PMID:25741868 PMID:29489751 |
|
NCBI chr 5:61,849,042...61,870,288
Ensembl chr 5:61,849,253...61,868,049
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
|
ISO |
ClinVar Annotator: match by term: CLEC7A-related condition |
ClinVar OMIM |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr 5:61,832,910...61,846,441
Ensembl chr 5:61,832,954...61,846,434
|
|
G |
CRP |
C-reactive protein, pentraxin-related |
treatment |
ISO |
|
RGD |
PMID:20879853 |
RGD:9495929 |
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
|
|
G |
TLR1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 8:30,147,600...30,155,454
Ensembl chr 8:30,147,624...30,155,466
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
G |
TLR6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 8:30,159,744...30,180,650
Ensembl chr 8:30,159,754...30,180,650
|
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
associated with Cerebrovascular Accident |
RGD |
PMID:14990394 |
RGD:4140926 |
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased secretion:plasma (rat) |
RGD |
PMID:19262391 |
RGD:4145069 |
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15607125 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
severity |
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:24211414 |
RGD:40925940 |
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
disease_progression |
ISO |
association with Cryptococcal neoformans infection. |
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr15:24,502,935...24,541,286
Ensembl chr15:24,503,108...24,541,283
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
|
RGD |
PMID:11238654 |
RGD:5128828 |
NCBI chr 3:28,360,868...28,472,940
Ensembl chr 3:28,360,873...28,473,456
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
|
ISO |
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse) |
RGD |
PMID:31645418 |
RGD:40818279 |
NCBI chr X:12,099,849...12,152,204
Ensembl chr X:12,093,242...12,151,286
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
severity |
ISO |
|
RGD |
PMID:21629785 |
RGD:6767559 |
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
|
|
G |
AMCF-II |
alveolar macrophage-derived chemotactic factor-II |
|
ISO |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 8:70,008,225...70,010,360
Ensembl chr 8:70,008,162...70,010,358
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:16014897 |
RGD:5129508 |
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:16461429 |
RGD:5129690 |
NCBI chr 5:63,088,778...63,098,750
Ensembl chr 5:63,088,778...63,098,750
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
|
|
G |
CAT |
catalase |
|
ISO |
protein:decreased expression:lung, plasma |
RGD |
PMID:19842849 |
RGD:5130748 |
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr10:32,110,366...32,112,529
Ensembl chr10:32,110,065...32,112,734
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
|
ISO |
|
RGD |
PMID:20483921 |
RGD:5130905 |
NCBI chr12:39,479,190...39,480,511
Ensembl chr12:39,478,882...39,481,082
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
|
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr12:21,857,286...21,869,211
Ensembl chr12:21,857,286...21,872,475
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:16210672 |
RGD:4144197 |
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:20949109 |
RGD:4892562 |
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:18643924 |
RGD:5133701 |
NCBI chr14:111,316,178...111,351,669
Ensembl chr14:111,315,141...111,351,868
|
|
G |
CSF3 |
colony stimulating factor 3 |
treatment disease_progression |
ISO |
associated with Peritonitis; |
RGD |
PMID:12352049 PMID:21373266 |
RGD:11039437 RGD:5133733 |
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
disease_progression |
ISO |
|
RGD |
PMID:17185469 |
RGD:5133739 |
NCBI chr 6:92,550,159...92,565,798
Ensembl chr 6:92,550,161...92,565,477
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
severity |
ISO |
|
RGD |
PMID:15618188 PMID:16299319 |
RGD:5135458 RGD:5135459 |
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 8:71,713,790...71,725,669
Ensembl chr 8:71,713,803...71,725,674
|
|
G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
severity |
ISO |
|
RGD |
PMID:11052817 PMID:19239431 PMID:21723409 |
RGD:5135062 RGD:5135065 RGD:5135234 |
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
|
|
G |
DEFB1 |
defensin, beta 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:10213993 |
RGD:4892266 |
NCBI chr15:38,076,057...38,077,899
Ensembl chr15:38,076,057...38,077,899
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:21897338 |
RGD:6893486 |
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
|
|
G |
FOXP3 |
forkhead box P3 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
|
|
G |
GP1BA |
glycoprotein Ib platelet subunit alpha |
exacerbates |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:27845343 |
RGD:42722624 |
NCBI chr12:51,975,810...51,979,428
Ensembl chr12:51,975,874...51,977,757
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
|
ISO |
mRNA:decreased expression:polymorphonuclear leukocyte |
RGD |
PMID:24465168 |
RGD:126848796 |
NCBI chr 2:5,209,435...5,227,543
Ensembl chr 2:5,209,439...5,227,758
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
severity |
ISO |
|
RGD |
PMID:19487810 |
RGD:5490274 |
NCBI chr13:196,925,731...196,951,398
Ensembl chr13:196,925,734...196,952,239
|
|
G |
IFNG |
interferon gamma |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
G |
IL10 |
interleukin 10 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:17911627 |
RGD:5000754 |
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:18802100 PMID:25398094 |
RGD:38501102 RGD:4889153 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:17664259 |
RGD:4889913 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
treatment |
ISO |
associated with Sepsis associated with Acinetobacter infectious disease |
RGD |
PMID:20959556 PMID:29508184 |
RGD:40818077 RGD:5144223 |
NCBI chr 3:51,868,549...51,902,454
Ensembl chr 3:51,846,792...51,951,383
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:18322242 PMID:18596024 |
RGD:4143205 RGD:4143206 |
|
|
G |
IL6 |
interleukin 6 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
|
RGD |
PMID:20439918 PMID:28120642 |
RGD:34888234 RGD:36049799 |
NCBI chr 5:30,524,704...30,601,067
Ensembl chr 5:30,526,793...30,609,921
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:11854220 |
RGD:5128725 |
NCBI chr 2:134,776,122...134,783,646
Ensembl chr 2:134,776,129...134,783,801
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20720199 |
RGD:4891951 |
NCBI chr 6:54,701,733...54,706,079
Ensembl chr 6:54,701,668...54,707,151
|
|
G |
ITGB3 |
integrin subunit beta 3 |
|
ISO |
protein:increased expression:lung, neutrophil |
RGD |
PMID:15114484 |
RGD:4993468 |
NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:11937559 |
RGD:5128871 |
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
severity treatment |
ISO |
associated with Agranulocytosis |
RGD |
PMID:7546648 PMID:18596024 PMID:25398094 |
RGD:10755357 RGD:38501102 RGD:4143205 |
|
|
G |
LOC110261221 |
cytochrome P450 2J2-like |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr 6:152,321,816...152,358,179
Ensembl chr 6:152,321,848...152,648,979
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
severity |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:18641104 |
RGD:4889477 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
MC1R |
melanocortin 1 receptor |
|
ISO |
|
RGD |
PMID:18304533 |
RGD:5687324 |
NCBI chr 6:181,225...182,187
Ensembl chr 6:181,225...182,187
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17202364 PMID:19535150 |
RGD:5129533 RGD:5130727 |
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:bronchoalveolar lavage Fluid: |
RGD |
PMID:11269653 |
RGD:5130992 |
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr18:42,464,667...42,509,135
Ensembl chr18:42,432,050...42,512,264
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
|
|
G |
PDPN |
podoplanin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:7864138 |
RGD:2292375 |
NCBI chr 6:73,019,063...73,050,000
Ensembl chr 6:73,019,057...73,049,996
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:12524254 |
RGD:724645 |
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
|
|
G |
PGF |
placental growth factor |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:21527775 |
RGD:127285594 |
NCBI chr14:99,929,590...100,021,619
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:28387756 |
RGD:127229944 |
NCBI chr 7:74,951,145...74,955,255
Ensembl chr 7:74,951,145...74,955,251
|
|
G |
RORC |
RAR related orphan receptor C |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 4:97,374,672...97,399,017
Ensembl chr 4:97,375,136...97,400,209
|
|
G |
SERPINE1 |
serpin family E member 1 |
severity |
ISO |
|
RGD |
PMID:17032919 |
RGD:4144840 |
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
|
|
G |
SFTPA1 |
surfactant protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:12169586 |
RGD:4143464 |
NCBI chr14:82,091,178...82,095,393
Ensembl chr14:82,091,178...82,095,393
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
protein:increased expression:lung associated with Cystic Fibrosis;protein:increased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143403 RGD:4143464 |
NCBI chr 3:59,101,940...59,113,442
Ensembl chr 3:59,101,981...59,112,396
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
|
RGD |
PMID:12169586 PMID:18566429 |
RGD:4143464 RGD:4144114 |
NCBI chr14:6,440,309...6,443,104
Ensembl chr14:6,440,309...6,443,095
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
protein:increased expression:lung associated with Cystic Fibrosis;protein:decreased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143403 RGD:4143464 |
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:18192501 |
RGD:6892945 |
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18768871 PMID:19844782 |
RGD:4145337 RGD:4889533 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:16210672 PMID:20650991 |
RGD:4144172 RGD:4144197 |
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
|
|
G |
TLR5 |
toll like receptor 5 |
|
ISO |
|
RGD |
PMID:19801452 |
RGD:5129503 |
NCBI chr10:19,387,666...19,410,024
Ensembl chr10:19,387,666...19,410,024
|
|
G |
TLR6 |
toll like receptor 6 |
|
ISO |
|
RGD |
PMID:19844782 |
RGD:4889533 |
NCBI chr 8:30,159,744...30,180,650
Ensembl chr 8:30,159,754...30,180,650
|
|
G |
TLR9 |
toll like receptor 9 |
|
ISO |
|
RGD |
PMID:20360853 |
RGD:5130719 |
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
|
|
G |
TNF |
tumor necrosis factor |
treatment severity disease_progression |
ISO |
associated with Agranulocytosis |
RGD |
PMID:7546648 PMID:9310939 PMID:10650487 PMID:12958055 |
RGD:10449451 RGD:10450564 RGD:10755357 RGD:4143476 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
severity ameliorates |
ISO |
|
RGD |
PMID:16960786 PMID:22996209 PMID:24465168 |
RGD:126848796 RGD:126925987 RGD:127229902 |
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
|
|
G |
ZC3H12A |
zinc finger CCCH-type containing 12A |
|
ISO |
associated with Pseudomonas Infections |
RGD |
PMID:29695841 |
RGD:39938967 |
NCBI chr 6:93,541,334...93,551,200
Ensembl chr 6:93,541,334...93,551,193
|
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:17687719 |
RGD:4145098 |
NCBI chr 2:150,032,649...150,035,591
Ensembl chr 2:150,033,579...150,040,731
|
|
G |
CCL11 |
chemokine (C-C motif) ligand 11 |
severity |
ISO |
associated with Respiratory Syncytial Virus Infections protein:increased expression:nasal mucus |
RGD |
PMID:15681407 PMID:17297249 |
RGD:4145415 RGD:4145460 |
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19470255 |
RGD:5132271 |
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:decreased expression:myeloid dendritic cell (mouse) |
RGD |
PMID:20046053 |
RGD:4892291 |
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
|
|
G |
CRP |
C-reactive protein, pentraxin-related |
severity |
ISO |
|
RGD |
PMID:21284715 |
RGD:5131282 |
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
|
|
G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
associated with Pneumovirus Infections |
RGD |
PMID:16337014 |
RGD:4843953 |
NCBI chr X:62,380,778...62,407,736
Ensembl chr X:62,380,780...62,456,689
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
ISO |
DNA:SNP:promoter:rs2275913 (human) |
RGD |
PMID:20437253 |
RGD:4889139 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human) |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 2:807,685...842,096
|
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
|
RGD |
PMID:17097496 |
RGD:4140933 |
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
|
RGD |
PMID:19766783 |
RGD:4890362 |
NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
|
RGD |
PMID:18785972 |
RGD:4145604 |
NCBI chr 6:19,345,929...19,372,972
Ensembl chr 6:19,345,941...19,348,926
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
|
RGD |
PMID:14611812 |
RGD:2307195 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20628341 |
RGD:4891471 |
NCBI chr 6:19,296,726...19,301,506
Ensembl chr 6:19,296,637...19,302,737
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:14611812 PMID:19840961 |
RGD:2307195 RGD:4889978 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:trachea: |
RGD |
PMID:11518728 |
RGD:4145124 |
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
|
RGD |
PMID:11266944 |
RGD:2307206 |
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
associated with Respiratory Aspiration;protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 |
RGD:5135451 |
NCBI chr 8:71,713,790...71,725,669
Ensembl chr 8:71,713,803...71,725,674
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
human gene in a rat model |
RGD |
PMID:9595474 |
RGD:8662402 |
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
FOXP3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19840961 |
RGD:4889978 |
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
|
|
G |
GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
ISO |
|
RGD |
PMID:19737140 |
RGD:5135518 |
NCBI chr 7:74,705,499...74,708,781
Ensembl chr 7:74,705,409...74,708,790
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
|
RGD |
PMID:12973103 |
RGD:4145412 |
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16137903 |
|
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL13RA1 |
interleukin 13 receptor subunit alpha 1 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:97,300,960...97,353,754
Ensembl chr X:97,300,466...97,356,133
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:94,402,665...94,455,609
Ensembl chr X:94,402,676...94,439,060
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA:increased expression:trachea |
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11889437 |
RGD:4143176 |
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
MBL2 |
mannose binding lectin 2 |
resistance |
ISO |
DNA:transversion:5' utr:-290C>G rs7096206 (human) |
RGD |
PMID:19104434 |
RGD:4889456 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:20417130 |
RGD:5130759 |
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16969297 |
RGD:5131273 |
NCBI chr 4:94,626,317...94,631,194
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:18158963 |
RGD:5131450 |
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
associated with lung transplantation; protein:increased expression:lung |
RGD |
PMID:11112135 |
RGD:4892082 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:15136885 |
RGD:4892068 |
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage |
RGD |
PMID:11981419 |
RGD:5147386 |
NCBI chr 2:9,297,282...9,302,204
Ensembl chr 2:9,297,283...9,302,165
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:18347569 |
RGD:4143500 |
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
|
|
G |
TLR9 |
toll like receptor 9 |
|
ISO |
DNA:SNPs:promoter, 3' utr:g.-1485C>T (rs187084), rs352162 (human) |
RGD |
PMID:20227302 |
RGD:5130722 |
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
|
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:17384085 |
RGD:5132266 |
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
|
|
G |
HDAC2 |
histone deacetylase 2 |
treatment |
ISO |
|
RGD |
PMID:22708526 |
RGD:9590258 |
NCBI chr 1:79,867,713...79,901,597
Ensembl chr 1:79,863,094...79,901,585
|
|
G |
IFNG |
interferon gamma |
resistance |
ISO |
|
RGD |
PMID:20953328 |
RGD:4145525 |
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:20350425 |
RGD:4892019 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
disease_progression |
ISO |
associated with Plague |
RGD |
PMID:21356370 |
RGD:5134954 |
NCBI chr15:120,219,657...120,230,203
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
associated with Down Syndrome; protein:decreased secretion:serum (human) |
RGD |
PMID:19804807 |
RGD:4889483 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
|
G |
CD274 |
CD274 molecule |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724
|
|
G |
PDCD1 |
programmed cell death 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
|
|
G |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
severity |
ISO |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr 6:70,026,254...70,086,950
Ensembl chr 6:70,026,373...70,084,742
|
|
|
G |
CCL11 |
chemokine (C-C motif) ligand 11 |
|
ISO |
|
RGD |
PMID:11991282 |
RGD:4145442 |
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
|
|
G |
CFTR |
CF transmembrane conductance regulator |
susceptibility |
ISO |
DNA:deletion: :F508del(human) associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human) |
RGD |
PMID:10767489 PMID:15463907 |
RGD:4140475 RGD:4140484 |
NCBI chr18:28,627,717...28,818,209
Ensembl chr18:28,627,728...28,817,950
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:19386687 |
RGD:4891509 |
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse) |
RGD |
PMID:18631350 |
RGD:4145074 |
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
GC |
GC vitamin D binding protein |
susceptibility |
ISO |
|
RGD |
PMID:12096683 |
RGD:5129516 |
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:bronchial epithelium (rat) |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:Respiratory Mucosa |
RGD |
PMID:14582911 |
RGD:4759835 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11742275 |
RGD:4990461 |
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11798689 |
RGD:5130990 |
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:19938219 |
RGD:4891494 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NPY |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chr18:47,985,796...47,993,726
Ensembl chr18:47,985,725...47,992,667
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19263519 |
|
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
|
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human) |
RGD |
PMID:8845175 |
RGD:8661738 |
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
|
G |
CD8A |
CD8 subunit alpha |
ameliorates |
ISO |
protein:decreased expression:blood, T cell (human) |
RGD |
PMID:24639246 |
RGD:124715444 |
NCBI chr 3:57,999,228...58,029,768
Ensembl chr 3:57,998,891...58,029,760
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
protein:increased expression:uncinate process, nasal mucosa (human) |
RGD |
PMID:23613503 |
RGD:8696039 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human) |
RGD |
PMID:16549749 |
RGD:8549791 |
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
protein:decreased activity:serum: |
RGD |
PMID:23144819 |
RGD:8693716 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr11:7,371,328...7,438,111
Ensembl chr11:7,411,644...7,438,108
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 6:19,312,351...19,324,439
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15764644 |
RGD:5135489 |
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
treatment |
ISO |
|
RGD |
PMID:28343401 |
RGD:150521550 |
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19864593 |
RGD:5131210 |
NCBI chr15:120,219,657...120,230,203
|
|
G |
DEFB1 |
defensin, beta 1 |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus |
RGD |
PMID:15034083 |
RGD:4892264 |
NCBI chr15:38,076,057...38,077,899
Ensembl chr15:38,076,057...38,077,899
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 |
RGD:4143183 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 PMID:18279051 |
RGD:4143183 RGD:4143207 |
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion |
RGD |
PMID:20644177 |
RGD:4140459 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7734976 |
RGD:7401200 |
|
|
G |
PRDX5 |
peroxiredoxin 5 |
|
ISO |
associated with asthma;protein:increased expression:sputum (human) |
RGD |
PMID:18219526 |
RGD:41404684 |
NCBI chr 2:7,798,672...7,801,955
Ensembl chr 2:7,798,670...7,802,952
|
|
G |
TSLP |
thymic stromal lymphopoietin |
|
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 2:115,832,152...115,837,572
|
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:lung, macrophage (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:lung, lymphocyte (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
|
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
OMIM:263000 |
MouseDO |
|
|
NCBI chr14:6,440,309...6,443,104
Ensembl chr14:6,440,309...6,443,095
|
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 |
RGD:8693755 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:decreased expression:bronchiole epithelium |
RGD |
PMID:15364771 |
RGD:7364741 |
NCBI chr 2:757,897...790,321
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:insertion/deletion |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 2:807,685...842,096
|
|
G |
MUCL3 |
mucin like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22152429 |
|
NCBI chr 7:23,429,415...23,440,523
|
|
G |
TAP2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:10323341 |
RGD:5147847 |
NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,043,840...25,056,922
|
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:2612053 |
RGD:5130160 |
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
|
|
G |
GATA2 |
GATA binding protein 2 |
|
ISO |
associated with Pneumocystis Infections |
RGD |
PMID:16774119 |
RGD:9587813 |
NCBI chr13:71,981,139...71,997,626
Ensembl chr13:71,984,067...71,997,619
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 PMID:19752036 |
RGD:4145474 RGD:4145506 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:25746970 |
RGD:39938968 |
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:10639453 |
RGD:4891455 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
SFTPA1 |
surfactant protein A1 |
susceptibility |
ISO |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr14:82,091,178...82,095,393
Ensembl chr14:82,091,178...82,095,393
|
|
G |
SFTPD |
surfactant protein D |
susceptibility |
ISO |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 |
RGD:4145506 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
DNA:polymorphism:cds:allele AB (human) |
RGD |
PMID:4375858 PMID:6189297 |
RGD:39938844 RGD:5128836 |
NCBI chr 1:272,912,239...272,935,316
|
|
G |
APOL6 |
apolipoprotein L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:11,920,119...11,929,492
|
|
G |
ATF3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:130,772,259...130,829,678
Ensembl chr 9:130,772,262...130,785,506
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:21408070 |
RGD:5129492 |
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
|
|
G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
ISO |
|
RGD |
PMID:19362023 |
RGD:5130181 |
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:16804020 PMID:19959187 PMID:20653246 |
RGD:5130201 RGD:5130744 RGD:5130864 |
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CCL11 |
chemokine (C-C motif) ligand 11 |
|
ISO |
associated with Asthma;protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12707338 PMID:20656925 |
RGD:4145439 RGD:4145452 |
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung |
CTD RGD |
PMID:20967263 PMID:23326326 |
RGD:4891425 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CCL28 |
C-C motif chemokine ligand 28 |
resistance |
ISO |
|
RGD |
PMID:19847203 |
RGD:4892196 |
NCBI chr16:27,990,024...28,010,859
Ensembl chr16:27,985,167...28,010,858
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:16208318 PMID:20656925 |
RGD:4145452 RGD:4892131 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
CCL8 |
chemokine (C-C motif) ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:40,740,468...40,741,970
Ensembl chr12:40,740,023...40,742,022
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
severity |
ISO |
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) |
RGD |
PMID:18617426 PMID:19039768 PMID:20875295 |
RGD:4892063 RGD:4892119 RGD:4892122 |
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17825924 |
RGD:4144809 |
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
ISO |
|
RGD |
PMID:21191006 |
RGD:5131189 |
NCBI chr 2:71,394,414...71,397,711
Ensembl chr 2:71,394,391...71,397,968
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21389258 |
RGD:5131611 |
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19922665 |
RGD:5132270 |
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:10604996 PMID:19922665 |
RGD:5132270 RGD:5132623 |
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:mediastinal lymph node, B cell (mouse) |
RGD |
PMID:19933871 |
RGD:4892570 |
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
|
|
G |
CRP |
C-reactive protein, pentraxin-related |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21509252 |
RGD:5131277 |
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
|
RGD |
PMID:20427198 PMID:21474645 |
RGD:5131470 RGD:5131472 |
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20967263 PMID:21251691 |
RGD:4891425 RGD:5135026 |
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
|
|
G |
DDX60 |
DExD/H-box helicase 60 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:21,077,491...21,163,563
Ensembl chr14:21,083,350...21,163,561
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
mRNA:increased expression:frontal cortex (mouse) |
RGD |
PMID:21289196 |
RGD:5131660 |
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
|
|
G |
EIF2AK2 |
eukaryotic translation initiation factor 2 alpha kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:103,041,029...103,096,741
Ensembl chr 3:103,041,221...103,096,738
|
|
G |
FOXP2 |
forkhead box P2 |
|
ISO |
|
RGD |
PMID:18248790 |
RGD:11536002 |
NCBI chr18:31,335,102...31,890,523
Ensembl chr18:31,335,264...31,888,845
|
|
G |
GBP1 |
guanylate binding protein 1, interferon-inducible |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:127,425,699...127,442,132
Ensembl chr 4:127,425,200...127,442,127
|
|
G |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 8:130,532,256...130,591,158
Ensembl chr 8:130,533,877...130,590,841
|
|
G |
HERC6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 8:130,594,941...130,665,591
Ensembl chr 8:130,594,939...130,665,145
|
|
G |
IFI35 |
interferon induced protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:19,879,386...19,890,330
Ensembl chr12:19,879,387...19,890,314
|
|
G |
IFI44 |
interferon induced protein 44 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 6:134,634,679...134,649,857
Ensembl chr 6:134,633,615...134,650,203
|
|
G |
IFI44L |
interferon induced protein 44 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 6:134,660,230...134,679,212
Ensembl chr 6:134,659,639...134,679,331
|
|
G |
IFI6 |
interferon alpha inducible protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 6:84,852,782...84,858,072
Ensembl chr 6:84,852,793...84,857,982
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:68,930,998...68,985,145
Ensembl chr15:68,928,254...68,985,083
|
|
G |
IFIT2 |
interferon induced protein with tetratricopeptide repeats 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:101,193,421...101,204,292
Ensembl chr14:101,193,419...101,204,288
|
|
G |
IFIT3 |
interferon induced protein with tetratricopeptide repeats 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:101,237,403...101,249,486
Ensembl chr14:101,237,571...101,249,498
|
|
G |
IFIT3 |
interferon induced protein with tetratricopeptide repeats 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:101,214,730...101,225,169
Ensembl chr14:101,214,710...101,225,164
|
|
G |
IFIT5 |
interferon induced protein with tetratricopeptide repeats 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:101,254,818...101,266,105
Ensembl chr14:101,263,445...101,267,067
|
|
G |
IFITM3 |
interferon induced transmembrane protein 3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Influenza, severe, susceptibility to |
OMIM ClinVar |
PMID:20943977 PMID:22446628 |
|
NCBI chr 2:128,658...129,736
Ensembl chr 2:127,152...129,835
|
|
G |
IL10 |
interleukin 10 |
susceptibility |
ISO |
|
RGD |
PMID:20200252 |
RGD:4140426 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL12B |
interleukin 12B |
|
ISO |
|
RGD |
PMID:16389596 |
RGD:4145426 |
NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20003352 |
RGD:4888530 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19234203 PMID:20212069 PMID:21098221 |
RGD:4994196 RGD:4996471 RGD:4996472 |
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:21098221 |
RGD:4994196 |
NCBI chr10:65,022,227...65,054,385
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19265125 PMID:19783685 |
RGD:4889102 RGD:4889150 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL17RA |
interleukin 17 receptor A |
|
ISO |
|
RGD |
PMID:19783685 |
RGD:4889102 |
NCBI chr 5:69,461,280...69,480,343
Ensembl chr 5:69,461,290...69,480,112
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15606801 |
RGD:4889964 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11535264 |
RGD:4142860 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:9439800 PMID:20840779 |
RGD:4143203 RGD:4143228 |
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21603856 |
RGD:5147905 |
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
|
RGD |
PMID:21092162 |
RGD:5128546 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20731583 |
RGD:4143268 |
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
IRF7 |
interferon regulatory factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:372,235...375,572
Ensembl chr 2:372,238...375,378
|
|
G |
ISG15 |
ISG15 ubiquitin like modifier |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 6:63,363,201...63,364,211
Ensembl chr 6:63,363,173...63,364,208
|
|
G |
LAMP3 |
lysosomal associated membrane protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:121,081,717...121,117,660
Ensembl chr13:121,081,424...121,117,665
|
|
G |
LOC100512911 |
transmembrane protease serine 11D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20237084 PMID:23072892 |
|
NCBI chr 8:65,570,433...65,623,785
Ensembl chr 8:65,570,946...65,623,801
|
|
G |
LOC100519098 |
sterile alpha motif domain-containing protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:72,965,088...72,999,261
Ensembl chr 9:72,964,869...72,999,258
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
|
RGD |
PMID:20438620 |
RGD:4142822 |
|
|
G |
LY6E |
lymphocyte antigen 6 family member E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:1,336,112...1,341,112
Ensembl chr 4:1,337,196...1,340,786
|
|
G |
LYST |
lysosomal trafficking regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr14:55,433,163...55,634,011
Ensembl chr14:55,433,597...55,633,484
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung, heart, brain |
RGD |
PMID:20299740 |
RGD:5130855 |
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:204,843,049...204,868,927
Ensembl chr13:204,843,754...204,868,922
|
|
G |
MX2 |
MX dynamin like GTPase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:204,798,633...204,821,612
Ensembl chr13:204,798,629...204,831,957
|
|
G |
NOS1 |
nitric oxide synthase 1 |
|
ISO |
protein:increased expression:hippocampus |
RGD |
PMID:9552178 |
RGD:5132870 |
NCBI chr14:35,112,898...35,299,297
Ensembl chr14:35,113,184...35,295,944
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
mRNA:increased expression:olfactory epithelium mRNA,protein:increased expression:brain |
RGD |
PMID:17030871 PMID:17674769 PMID:18080188 |
RGD:4891919 RGD:4891937 RGD:4891952 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
OAS1 |
2'-5'-oligoadenylate synthetase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:38,851,083...38,867,427
Ensembl chr14:38,851,918...38,859,409
|
|
G |
OAS2 |
2'-5'-oligoadenylate synthetase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:38,827,667...38,847,697
Ensembl chr14:38,827,660...38,860,820
|
|
G |
OASL |
2'-5'-oligoadenylate synthetase like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:40,900,050...40,917,189
Ensembl chr14:40,899,856...40,917,266
|
|
G |
PARP12 |
poly(ADP-ribose) polymerase family member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr18:9,673,841...9,715,169
Ensembl chr18:9,674,944...9,716,743
|
|
G |
PLSCR1 |
phospholipid scramblase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:86,836,288...86,869,569
Ensembl chr13:86,834,587...86,869,297
|
|
G |
PRF1 |
perforin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr14:73,515,306...73,520,256
Ensembl chr14:73,512,769...73,520,202
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16272346 |
RGD:5143925 |
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:33,891,720...33,976,151
Ensembl chr10:33,891,763...33,933,455
|
|
G |
RSAD2 |
radical S-adenosyl methionine domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:128,880,853...128,897,809
Ensembl chr 3:128,877,186...128,897,815
|
|
G |
RTP4 |
receptor transporter protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:125,098,503...125,106,770
|
|
G |
SCO2 |
synthesis of cytochrome C oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:220,801...222,678
Ensembl chr 5:220,814...225,307
|
|
G |
SERPING1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:13,324,160...13,338,826
Ensembl chr 2:13,324,158...13,338,663
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:16787926 |
RGD:4143518 |
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
|
|
G |
SIGLEC1 |
sialic acid binding Ig like lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:31,994,505...32,021,239
Ensembl chr17:31,994,632...32,021,239
|
|
G |
SLA-8 |
MHC class I antigen 8 |
|
ISO |
|
RGD |
PMID:21087648 |
RGD:5144131 |
NCBI chr 7:23,622,352...23,625,818
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23129053 |
|
NCBI chr 2:8,782,030...8,800,998
Ensembl chr 2:8,782,060...8,800,997
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
|
|
G |
TDRD7 |
tudor domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:239,285,628...239,368,558
Ensembl chr 1:239,271,916...239,368,550
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
protein:increased expression:monocyte |
RGD |
PMID:18657324 |
RGD:4145339 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
G |
TLR3 |
toll like receptor 3 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16789835 PMID:18654661 |
RGD:5129136 RGD:5129219 |
NCBI chr15:46,966,262...46,977,774
Ensembl chr15:46,969,006...46,979,291
|
|
G |
TMPRSS2 |
transmembrane serine protease 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:20237084 PMID:21123387 PMID:23072892 PMID:26889029 PMID:28778717 PMID:31391268 More...
|
|
NCBI chr13:204,874,759...204,905,411
Ensembl chr13:204,874,764...204,914,490
|
|
G |
TMPRSS4 |
transmembrane serine protease 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26889029 |
|
NCBI chr 9:45,400,263...45,436,936
Ensembl chr 9:45,400,600...45,435,916
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21062445 |
RGD:5128683 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TNFAIP6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:862,013...881,352
Ensembl chr15:862,015...881,461
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:17182684 PMID:19497758 |
RGD:5131157 RGD:5131432 |
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
|
|
G |
TOR1B |
torsin family 1 member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:269,966,919...269,973,702
Ensembl chr 1:269,967,008...269,973,693
|
|
G |
TREX1 |
three prime repair exonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr13:31,177,604...31,180,764
Ensembl chr13:31,179,291...31,180,747
|
|
G |
UBE2L6 |
ubiquitin conjugating enzyme E2 L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:13,354,088...13,368,446
Ensembl chr 2:13,354,014...13,370,792
|
|
G |
UGCG |
UDP-glucose ceramide glucosyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33639165 |
|
NCBI chr 1:252,651,850...252,690,817
Ensembl chr 1:252,651,879...252,688,550
|
|
G |
ZCCHC2 |
zinc finger CCHC-type containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:158,964,816...159,022,143
Ensembl chr 1:158,964,819...159,022,271
|
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung, alveolar macrophage (human) |
RGD |
PMID:19218648 |
RGD:4145518 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
protein:increased expression:bronchoalveolar lavage (rat) |
RGD |
PMID:10988147 |
RGD:11062092 |
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
|
ISO |
protein:increased expression:hyperplastic lung epithelium, alveolus (human) |
RGD |
PMID:20718723 |
RGD:6893300 |
NCBI chr 2:69,280,940...69,290,267
Ensembl chr 2:69,276,336...69,294,382
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:21444868 |
RGD:7245946 |
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15467329 |
RGD:5144148 |
NCBI chr 2:9,297,282...9,302,204
Ensembl chr 2:9,297,283...9,302,165
|
|
G |
TERT |
telomerase reverse transcriptase |
|
ISO |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:9536098 PMID:15814878 PMID:15885610 PMID:16247010 PMID:17460043 PMID:17576681 PMID:18042801 PMID:18460650 PMID:18635888 PMID:18931339 PMID:19561322 PMID:19674077 PMID:19760749 PMID:20301779 PMID:20502709 PMID:21436073 PMID:21520174 PMID:21602826 PMID:22853774 PMID:23538340 PMID:23716176 PMID:23901009 PMID:24033266 PMID:24763404 PMID:24833766 PMID:24983628 PMID:25365545 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26580448 PMID:26859482 PMID:27192671 PMID:27418648 PMID:27540018 PMID:27848944 PMID:28104920 PMID:28492532 PMID:29036293 PMID:29483670 PMID:30426156 PMID:30523342 PMID:30791107 PMID:31268371 PMID:33709208 PMID:33850299 PMID:34019641 PMID:34482403 PMID:34565437 PMID:34890115 PMID:35776903 PMID:36622818 More...
|
|
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
|
|
|
G |
ATM |
ATM serine/threonine kinase |
exacerbates |
ISO |
|
RGD |
PMID:31509427 |
RGD:126779564 |
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,657...36,759,552
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
Associated with Acute Lung Injury |
RGD |
PMID:29516781 |
RGD:124713566 |
NCBI chr X:82,981,512...83,014,475
Ensembl chr X:82,981,515...83,014,573
|
|
G |
DUOX1 |
dual oxidase 1 |
|
ISO |
protein:decreased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr 1:126,572,533...126,603,084
Ensembl chr 1:126,572,492...126,603,082
|
|
G |
DUOX2 |
dual oxidase 2 |
severity |
ISO |
|
RGD |
PMID:25751630 PMID:28936773 PMID:29556357 |
RGD:40924644 RGD:40925921 RGD:40925925 |
NCBI chr 1:126,620,468...126,641,406
Ensembl chr 1:126,620,510...126,641,406
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr15:68,930,998...68,985,145
Ensembl chr15:68,928,254...68,985,083
|
|
G |
IL21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:25251568 |
RGD:127285548 |
NCBI chr 8:101,532,742...101,540,712
Ensembl chr 8:101,532,531...101,541,713
|
|
G |
IL27 |
interleukin 27 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:22343630 |
RGD:126790513 |
NCBI chr 3:18,421,962...18,427,916
Ensembl chr 3:18,421,981...18,427,915
|
|
G |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
ISO |
|
RGD |
PMID:26241898 |
RGD:11055126 |
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
ameliorates |
ISO |
|
RGD |
PMID:21562316 |
RGD:41412197 |
NCBI chr15:24,502,935...24,541,286
Ensembl chr15:24,503,108...24,541,283
|
|
G |
MAVS |
mitochondrial antiviral signaling protein |
disease_progression |
ISO |
|
RGD |
PMID:27438481 |
RGD:40903047 |
NCBI chr17:31,850,646...31,869,273
Ensembl chr17:31,850,900...31,869,188
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:30945621 PMID:31653718 |
RGD:126777673 RGD:126777680 |
NCBI chr13:204,843,049...204,868,927
Ensembl chr13:204,843,754...204,868,922
|
|
G |
PLAC8 |
placenta associated 8 |
|
ISO |
|
RGD |
PMID:32639988 |
RGD:40925929 |
NCBI chr 8:135,250,761...135,279,091
|
|
G |
PPIA |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:27354005 |
RGD:150429624 |
NCBI chr18:50,563,130...50,566,857
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr10:33,891,720...33,976,151
Ensembl chr10:33,891,763...33,933,455
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
susceptibility exacerbates |
ISO |
|
RGD |
PMID:27321907 PMID:28410401 PMID:32200799 |
RGD:127229911 RGD:127229918 RGD:127229922 |
NCBI chr 7:74,951,145...74,955,255
Ensembl chr 7:74,951,145...74,955,251
|
|
G |
STAT2 |
signal transducer and activator of transcription 2 |
exacerbates |
ISO |
|
RGD |
PMID:30337919 |
RGD:41789626 |
NCBI chr 5:21,733,030...21,748,960
Ensembl chr 5:21,733,035...21,751,354
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
severity |
ISO |
|
RGD |
PMID:11160230 |
RGD:11528533 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20926800 |
RGD:7483599 |
NCBI chr15:129,172,743...129,176,069
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
disease_progression |
ISO |
|
RGD |
PMID:17379855 |
RGD:7483617 |
NCBI chr 1:2,016,600...2,034,172
Ensembl chr 1:2,018,608...2,019,821
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:17298426 |
RGD:5135501 |
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
|
|
G |
CYP2C49 |
cytochrome P450 2C49 |
treatment |
ISO |
DNA:polymorphisms:cds: |
RGD |
PMID:26861072 |
RGD:124713410 |
NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr 2:77,513,769...77,516,118
Ensembl chr 2:77,509,344...77,516,027
|
|
G |
GP91-PHOX |
NADPH oxidase heavy chain subunit |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr X:33,654,656...33,678,346
Ensembl chr X:33,643,648...33,680,580
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:21807912 |
RGD:8698654 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
DNA:SNP:exon:rs5030737(human) |
RGD |
PMID:17311505 |
RGD:8693758 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
PTX3 |
pentraxin 3 |
severity |
ISO |
DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 protein:increased expression:bronchoalveolar lavage fluid (human) |
RGD |
PMID:28487045 PMID:30275011 |
RGD:38501097 RGD:38508892 |
NCBI chr13:97,273,594...97,279,570
Ensembl chr13:97,273,594...97,279,569
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:16113258 |
RGD:8553022 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
G |
TLR4 |
toll like receptor 4 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.D299G(human) |
RGD |
PMID:18275280 |
RGD:5130863 |
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
|
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
treatment |
ISO |
|
RGD |
PMID:12917249 |
RGD:11528529 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
ISO |
DNA:SNPs:3'utr,intron:multiple |
RGD |
PMID:22384201 |
RGD:39938996 |
NCBI chr 2:71,394,414...71,397,711
Ensembl chr 2:71,394,391...71,397,968
|
|
G |
FGF2 |
fibroblast growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism, haplotype:promoter:-889C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, serum |
RGD |
PMID:24360996 |
RGD:40903005 |
NCBI chr13:34,928,455...34,948,250
Ensembl chr13:34,928,439...34,948,229
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
DNA:polymorphism, haplotype: :-511C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
|
|
G |
MBL2 |
mannose binding lectin 2 |
treatment |
ISO |
|
RGD |
PMID:17335555 |
RGD:8693746 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
PTX3 |
pentraxin 3 |
susceptibility no_association |
ISO |
protein:increased expression:bronchoalveolar lavage fluid, plasma (human) DNA:SNP:intron:rs1840680 (human) protein:increased expression:plasma DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527 |
RGD |
PMID:29020397 PMID:29964232 |
RGD:38501098 RGD:38508894 |
NCBI chr13:97,273,594...97,279,570
Ensembl chr13:97,273,594...97,279,569
|
|
G |
VEGFA |
vascular endothelial growth factor A |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:11207292 |
RGD:38549344 |
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
IL23A |
interleukin 23 subunit alpha |
severity |
ISO |
|
RGD |
PMID:16157683 |
RGD:39457940 |
NCBI chr 5:21,732,416...21,733,981
Ensembl chr 5:21,732,165...21,734,267
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
severity |
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20864681 PMID:22729155 |
RGD:35316077 RGD:36049798 |
NCBI chr 5:30,524,704...30,601,067
Ensembl chr 5:30,526,793...30,609,921
|
|
G |
LCN2 |
lipocalin 2 |
exacerbates ameliorates |
ISO |
protein:increased expression:lung protein:increased expression:serum |
RGD |
PMID:19342674 PMID:25234944 PMID:29633303 |
RGD:126725082 RGD:126725084 RGD:126725085 |
NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644
|
|
G |
PLAC8 |
placenta associated 8 |
severity |
ISO |
|
RGD |
PMID:17404296 |
RGD:40924563 |
NCBI chr 8:135,250,761...135,279,091
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
ISO |
|
RGD |
PMID:24396044 |
RGD:126925976 |
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
|
|
G |
AMCF-II |
alveolar macrophage-derived chemotactic factor-II |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 8:70,008,225...70,010,360
Ensembl chr 8:70,008,162...70,010,358
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:16113250 |
RGD:4891897 |
NCBI chr 6:19,312,351...19,324,439
|
|
G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr15:120,219,657...120,230,203
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11349020 |
|
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:11083766 |
RGD:4889865 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:19073229 |
RGD:12910934 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr18:42,464,667...42,509,135
Ensembl chr18:42,432,050...42,512,264
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
|
|
G |
TLR5 |
toll like receptor 5 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Legionnaire disease, susceptibility to |
ClinVar OMIM |
PMID:14623910 PMID:16027372 PMID:23447684 |
|
NCBI chr10:19,387,666...19,410,024
Ensembl chr10:19,387,666...19,410,024
|
|
G |
TLR9 |
toll like receptor 9 |
|
ISO |
|
RGD |
PMID:18426877 |
RGD:5130707 |
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
|
|
G |
ATP1B2 |
ATPase Na+/K+ transporting subunit beta 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr12:52,925,697...52,932,638
Ensembl chr12:52,925,693...52,932,635
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
|
ISO |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr12:39,479,190...39,480,511
Ensembl chr12:39,478,882...39,481,082
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (mouse) |
RGD |
PMID:18717637 |
RGD:4891914 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
CCL8 |
chemokine (C-C motif) ligand 8 |
|
ISO |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr12:40,740,468...40,741,970
Ensembl chr12:40,740,023...40,742,022
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:lung, T-helper cell (mouse) |
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
|
|
G |
CLEC5A |
C-type lectin domain containing 5A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr18:8,004,423...8,014,390
Ensembl chr18:8,004,448...8,016,308
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr15:93,556,914...93,595,678
Ensembl chr15:93,526,603...93,596,363
|
|
G |
COL6A2 |
collagen type VI alpha 2 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
|
|
G |
CRP |
C-reactive protein, pentraxin-related |
|
ISO |
|
RGD |
PMID:21426633 |
RGD:5131292 |
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
|
|
G |
DNASE1L3 |
deoxyribonuclease 1L3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr13:39,958,384...39,976,114
Ensembl chr13:39,958,387...39,975,946
|
|
G |
FCER2 |
Fc epsilon receptor II |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 2:71,454,046...71,468,149
Ensembl chr 2:71,453,824...71,468,149
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
|
|
G |
GALC |
galactosylceramidase |
|
ISO |
associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) associated with Guillain-Barre syndrome; protein:increased expression:serum (human) protein:increased expression:serum (mouse) |
RGD |
PMID:12225900 PMID:27490360 PMID:29301655 PMID:30396892 |
RGD:38599168 RGD:38599169 RGD:38599171 RGD:38599172 |
NCBI chr 7:109,894,576...109,961,407
Ensembl chr 7:109,894,578...109,961,413
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:17158962 |
RGD:5143920 |
NCBI chr 1:121,505,677...121,525,416
Ensembl chr 1:121,505,751...121,525,252
|
|
G |
HTRA3 |
HtrA serine peptidase 3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 8:2,794,780...2,819,686
Ensembl chr 8:2,793,799...2,820,184
|
|
G |
IFNG |
interferon gamma |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:7935058 |
RGD:10755754 |
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL22RA2 |
interleukin 22 receptor subunit alpha 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 1:27,073,481...27,090,635
Ensembl chr 1:27,073,610...27,091,236
|
|
G |
INHBA |
inhibin subunit beta A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr12:53,115,379...53,117,128 NCBI chr18:52,889,684...52,909,260
Ensembl chr18:52,889,684...52,900,967
|
|
G |
KLRF1 |
killer cell lectin like receptor F1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 5:62,032,559...62,044,856
Ensembl chr 5:62,032,574...62,043,988
|
|
G |
LOC100623720 |
collagen alpha-1(VI) chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr13:208,295,245...208,321,789
Ensembl chr13:208,295,451...208,313,127
|
|
G |
MS4A1 |
membrane spanning 4-domains A1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 2:11,216,238...11,229,060
Ensembl chr 2:11,215,901...11,222,914
|
|
G |
PLD4 |
phospholipase D family member 4 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
|
|
G |
SPIB |
Spi-B transcription factor |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 6:55,272,847...55,280,881
Ensembl chr 6:55,272,890...55,280,874
|
|
G |
TCF7 |
transcription factor 7 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 2:136,422,740...136,456,323
Ensembl chr 2:136,422,940...136,457,910
|
|
G |
TCL1A |
TCL1 family AKT coactivator A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 7:116,933,785...116,939,353
Ensembl chr 7:116,934,948...116,939,320
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TNFRSF13C |
TNF receptor superfamily member 13C |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 5:6,699,812...6,703,403
Ensembl chr 5:6,699,878...6,703,656
|
|
|
G |
PTCH1 |
patched 1 |
|
ISO |
mRNA:decreased expression:epithelium of nasopharynx |
RGD |
PMID:23001130 |
RGD:150523839 |
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
|
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19725899 |
RGD:5686851 |
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
|
|
G |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19389874 |
|
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:nasal turbinate |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr11:7,371,328...7,438,111
Ensembl chr11:7,411,644...7,438,108
|
|
G |
CAT |
catalase |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:20493834 |
RGD:5130771 |
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
protein:increased expression:nasal turbinate, mucosa (human) |
RGD |
PMID:9865755 |
RGD:8548839 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:Nasal Mucosa |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20226305 |
RGD:5132269 |
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:nasal mucosa, dendritic cell (human) |
RGD |
PMID:17088138 |
RGD:4892343 |
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
|
|
G |
CHIA |
chitinase acidic |
|
ISO |
mRNA, protein:increased expression:turbinate, mucosa (human) |
RGD |
PMID:20422678 |
RGD:5037226 |
NCBI chr 4:109,035,323...109,046,499
Ensembl chr 4:109,035,326...109,046,499
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) |
RGD |
PMID:19833116 |
RGD:5131984 |
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:17727088 |
RGD:4892590 |
NCBI chr 2:85,732,082...85,747,552
Ensembl chr 2:85,732,189...85,750,858
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
mRNA, protein:increased expression: nasal mucosa |
RGD |
PMID:16540907 |
RGD:4145406 |
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human) |
RGD |
PMID:19047814 PMID:19968652 |
RGD:4145464 RGD:4145520 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IFNGR1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr 1:27,037,151...27,061,095
Ensembl chr 1:27,037,165...27,061,093
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
mRNA, protein:increased expression:nasal mucosa |
RGD |
PMID:8520776 |
RGD:4782826 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:19226302 |
RGD:4889151 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNP:promoter:c. -607A>C (rs1946518) (human) |
RGD |
PMID:16406079 |
RGD:4889924 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism:exon:c.4845G>T (human) |
RGD |
PMID:14533660 |
RGD:4142859 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
ISO |
|
RGD |
PMID:18637763 |
RGD:5037238 |
NCBI chr 3:52,192,912...52,334,734
Ensembl chr 3:52,192,915...52,288,485
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:17608155 |
RGD:8662959 |
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:9237816 PMID:15329007 PMID:21171297 |
RGD:5128559 RGD:7829804 RGD:7829817 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
IL5 |
interleukin 5 |
|
ISO |
protein: increased levels: sputum |
RGD |
PMID:22186238 |
RGD:5687140 |
NCBI chr 2:134,832,143...134,846,141
Ensembl chr 2:134,832,147...134,835,212
|
|
G |
LOC100739508 |
glutathione S-transferase P-like |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:17181111 |
RGD:4142523 |
NCBI chr 2:5,005,498...5,009,247
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:nasal mucosa |
RGD |
PMID:14587983 |
RGD:4892078 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
DNA:snp:promoter:g.-786T>C (human) |
RGD |
PMID:18086269 |
RGD:4892054 |
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
protein:altered expression:nasal mucosa |
RGD |
PMID:20185258 |
RGD:4892593 |
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (human) |
RGD |
PMID:17116814 |
RGD:8552811 |
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
protein:increased expression:respiratory system epithelium |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
|
|
G |
TBXA2R |
thromboxane A2 receptor |
treatment |
ISO |
|
RGD |
PMID:15247523 |
RGD:11059532 |
NCBI chr 2:75,068,413...75,081,305
Ensembl chr 2:75,068,698...75,087,731
|
|
|
G |
PLAU |
plasminogen activator, urokinase |
|
ISO |
Gene product used in treatment of disease |
RGD |
PMID:20304453 |
RGD:4891955 |
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
|
|
G |
TNC |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 1:255,533,235...255,630,381
Ensembl chr 1:255,533,238...255,630,376
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
treatment |
ISO |
|
RGD |
PMID:20819512 |
RGD:127284851 |
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum: protein:increased activity:serum: protein:increased activity:pleural fluid: |
RGD |
PMID:1689629 PMID:1818842 PMID:18357489 PMID:21860532 |
RGD:152995280 RGD:152995288 RGD:152995292 RGD:152998934 |
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
|
|
G |
ADA2 |
adenosine deaminase 2 |
treatment |
ISO |
|
RGD |
PMID:8656037 |
RGD:152995258 |
NCBI chr 5:69,526,413...69,554,640
Ensembl chr 5:69,526,435...69,554,661
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20337996 |
RGD:4891473 |
NCBI chr 6:19,296,726...19,301,506
Ensembl chr 6:19,296,637...19,302,737
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:pleural fluid, natural killer cell (human) |
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
|
|
G |
FOXP3 |
forkhead box P3 |
disease_progression |
ISO |
associated with human immunodeficiency virus infectious disease; |
RGD |
PMID:21303360 |
RGD:36947878 |
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
DNA:repeat (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
|
|
G |
IL27 |
interleukin 27 |
exacerbates |
ISO |
protein:increased expression:alveolar system (human) associated with Pleural Effusion;protein:increased expression:pleural fluid (human) |
RGD |
PMID:23962500 PMID:25753767 PMID:28844060 PMID:31819557 |
RGD:126790505 RGD:126790517 RGD:126790523 RGD:126790549 |
NCBI chr 3:18,421,962...18,427,916
Ensembl chr 3:18,421,981...18,427,915
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:pleural fluid: |
RGD |
PMID:23301222 |
RGD:39939042 |
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
DNA:polymorphism: :3953T>C (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:pleura: |
RGD |
PMID:18715875 |
RGD:5129700 |
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:18295348 |
RGD:4144193 |
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
|
|
G |
TNC |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 1:255,533,235...255,630,381
Ensembl chr 1:255,533,238...255,630,376
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
|
RGD |
PMID:16860713 |
RGD:5128847 |
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:9109363 |
RGD:4890429 |
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:15784654 |
RGD:2306907 |
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:11853231 |
RGD:5129218 |
NCBI chr 7:117,491,350...117,492,410
Ensembl chr 7:117,491,350...117,492,410
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:9208140 PMID:15316088 |
RGD:4891029 RGD:4891041 |
NCBI chr 7:117,438,622...117,472,005
Ensembl chr 7:117,438,713...117,472,005
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased activity:pleural cavity |
RGD |
PMID:18256172 |
RGD:5129520 |
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:19778612 |
RGD:5130749 |
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CCL11 |
chemokine (C-C motif) ligand 11 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:11564646 PMID:11877329 |
RGD:4145443 RGD:4145479 |
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
|
|
G |
CCL25 |
C-C motif chemokine ligand 25 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:18056919 |
RGD:5130924 |
NCBI chr 2:71,175,066...71,206,950
Ensembl chr 2:71,175,075...71,206,950
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung (mouse) |
RGD |
PMID:18672096 |
RGD:4890016 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
associated with Mycobacterium Infections |
RGD |
PMID:17158890 |
RGD:4145643 |
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,286,467
|
|
G |
CSF3 |
colony stimulating factor 3 |
|
ISO |
|
RGD |
PMID:8841835 |
RGD:11039424 |
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO |
|
RGD |
PMID:14527170 PMID:21549112 |
RGD:5135064 RGD:5135449 |
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
|
|
G |
EDNRA |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:15107459 |
RGD:4892325 |
NCBI chr 8:81,210,750...81,279,053
Ensembl chr 8:81,209,327...81,276,853
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:20860667 |
RGD:10450565 |
NCBI chr 2:77,513,769...77,516,118
Ensembl chr 2:77,509,344...77,516,027
|
|
G |
ESR1 |
estrogen receptor 1 |
|
ISO |
|
RGD |
PMID:17035596 |
RGD:4892303 |
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) CTD Direct Evidence: marker/mechanism protein:increased expression:bronchial epithelium (mouse) |
RGD CTD |
PMID:11181422 PMID:19056932 PMID:19714575 |
RGD:4145510 RGD:4145519 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:10823416 |
RGD:4990464 |
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
|
|
G |
IL17A |
interleukin 17A |
treatment |
ISO |
|
RGD |
PMID:21898269 |
RGD:7175307 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:8491511 |
RGD:4143233 |
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
|
ISO |
protein:increased expression:lung protein:increased expression:pleural cavity, exudate (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11181422 PMID:20141620 PMID:20175894 PMID:21898269 |
RGD:4142808 RGD:4142826 RGD:7175307 |
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:11577999 |
RGD:5130991 |
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
|
RGD |
PMID:14673141 |
RGD:6893408 |
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:pleural cavity (rat) |
RGD |
PMID:20141620 PMID:21898269 |
RGD:4142808 RGD:7175307 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
PLA2G6 |
phospholipase A2 group VI |
|
ISO |
|
RGD |
PMID:15003994 |
RGD:6482741 |
NCBI chr 5:9,713,809...9,777,921
Ensembl chr 5:9,713,873...9,777,918
|
|
G |
PTAFR |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:8395390 |
RGD:10043147 |
NCBI chr 6:85,235,390...85,272,360
Ensembl chr 6:85,235,394...85,261,760
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:15740981 PMID:20141620 |
RGD:4142808 RGD:5143929 |
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
SELP |
selectin P |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD RGD |
PMID:11181422 PMID:21147071 |
RGD:6219005 |
NCBI chr 4:81,376,804...81,401,240
Ensembl chr 4:81,365,740...81,399,955
|
|
G |
SERPINE1 |
serpin family E member 1 |
susceptibility |
ISO |
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human): |
RGD |
PMID:23052617 |
RGD:13207414 |
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11161459 PMID:11181422 PMID:20141620 |
RGD:4142808 RGD:4143474 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:12773506 |
RGD:4890419 |
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
|
|
|
G |
AICDA |
activation induced cytidine deaminase |
|
ISO |
|
RGD |
PMID:26456931 |
RGD:11098923 |
NCBI chr 5:62,777,236...62,787,342
Ensembl chr 5:62,777,352...62,787,369
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20231413 |
RGD:4890435 |
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:30646846 |
RGD:124715470 |
NCBI chr X:82,981,512...83,014,475
Ensembl chr X:82,981,515...83,014,573
|
|
G |
C3 |
complement C3 |
disease_progression |
ISO |
protein:decreased expression:serum associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion |
RGD |
PMID:20405 PMID:15972516 PMID:17956621 |
RGD:5129509 RGD:5129523 RGD:5130163 |
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
|
|
G |
C5 |
complement C5 |
severity |
ISO |
|
RGD |
PMID:7814608 |
RGD:5130159 |
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
|
RGD |
PMID:16455992 |
RGD:4892130 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17185649 |
RGD:4144788 |
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
|
|
G |
CHI3L1 |
chitinase 3 like 1 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:10515841 |
RGD:4892626 |
NCBI chr 9:113,885,541...113,895,033
Ensembl chr 9:113,885,542...113,895,131
|
|
G |
CRHR1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr12:17,251,361...17,306,308
Ensembl chr12:17,252,020...17,306,285
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr18:42,251,755...42,296,457
Ensembl chr18:42,251,749...42,295,467
|
|
G |
CRP |
C-reactive protein, pentraxin-related |
disease_progression |
ISO |
|
RGD |
PMID:21281676 |
RGD:5131293 |
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20381636 |
RGD:5135285 |
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
|
|
G |
DEFB1 |
defensin, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr15:38,076,057...38,077,899
Ensembl chr15:38,076,057...38,077,899
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:17348295 |
RGD:4145366 |
|
|
G |
HP |
haptoglobin |
|
ISO |
|
RGD |
PMID:19396720 |
RGD:5147385 |
NCBI chr 6:14,980,382...14,985,245
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
protein:increased expression:alveolar macrophage, bronchial epithelial cell |
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr10:65,022,227...65,054,385
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
|
RGD |
PMID:19995896 |
RGD:4888531 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15770015 |
RGD:4889960 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20643849 |
RGD:4143255 |
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:17822444 |
RGD:5128869 |
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
|
|
G |
LEPR |
leptin receptor |
|
ISO |
|
RGD |
PMID:21148797 |
RGD:5128846 |
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
|
|
G |
MASP2 |
MBL associated serine protease 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12904520 |
|
NCBI chr 6:71,224,637...71,243,041
Ensembl chr 6:71,224,637...71,243,874
|
|
G |
MBL2 |
mannose binding lectin 2 |
no_association |
ISO |
DNA:mutations:5' utr, exon:multiple (human) DNA:polymorphisms:5' utr, exon:multiple (human) |
RGD |
PMID:12047967 PMID:18641104 |
RGD:4889477 RGD:4889478 |
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:17056580 |
RGD:4891950 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:20505137 |
RGD:127285597 |
NCBI chr14:99,929,590...100,021,619
|
|
G |
SFTPD |
surfactant protein D |
severity |
ISO |
|
RGD |
PMID:16255775 |
RGD:4143519 |
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
|
|
G |
SIRT1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
|
|
G |
STING1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
|
RGD |
PMID:29263110 |
RGD:39128230 |
NCBI chr 2:141,359,402...141,367,222
Ensembl chr 2:141,358,993...141,367,198
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:19956717 |
RGD:4145321 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:9032201 PMID:17348295 |
RGD:4143479 RGD:4145366 |
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
|
RGD |
PMID:19596984 PMID:24752755 |
RGD:126928121 RGD:127229903 |
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
|
|
|
G |
AZIN1 |
antizyme inhibitor 1 |
|
ISO |
mRNA:increased expression:alveolar macrophage |
RGD |
PMID:19158080 |
RGD:14700806 |
NCBI chr 4:34,221,368...34,257,261
Ensembl chr 4:34,234,679...34,257,134
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:17169032 |
RGD:5129525 |
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20618689 |
RGD:4891428 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CD40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:10968950 |
RGD:8547797 |
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:19487471 |
RGD:5131475 |
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
IL23A |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:17403873 |
RGD:39458043 |
NCBI chr 5:21,732,416...21,733,981
Ensembl chr 5:21,732,165...21,734,267
|
|
G |
IL33 |
interleukin 33 |
treatment |
ISO |
|
RGD |
PMID:21220696 |
RGD:40400892 |
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9617869 |
RGD:5131424 |
NCBI chr 4:94,626,317...94,631,194
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
mRNA:increased expression:alveolar macrophage protein:decreased dimerization:alveolar macrophage |
RGD |
PMID:20377877 PMID:20558778 |
RGD:4144112 RGD:4891486 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
SFTPA1 |
surfactant protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:82,091,178...82,095,393
Ensembl chr14:82,091,178...82,095,393
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 3:59,101,940...59,113,442
Ensembl chr 3:59,101,981...59,112,396
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:6,440,309...6,443,104
Ensembl chr14:6,440,309...6,443,095
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18400546 |
RGD:4145341 |
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
|
|
|
G |
ABCF1 |
ATP binding cassette subfamily F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 7:23,126,255...23,144,030
Ensembl chr 7:23,126,283...23,143,994
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
severity |
ISO |
DNA:polymorphism:cds:allele A (human) |
RGD |
PMID:4375858 |
RGD:39938844 |
NCBI chr 1:272,912,239...272,935,316
|
|
G |
ACE |
angiotensin I converting enzyme |
disease_progression |
ISO |
associated with Hypertension |
RGD |
PMID:17727310 PMID:19455553 PMID:20051911 |
RGD:4140916 RGD:4140918 RGD:4140922 |
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
ADORA1 |
adenosine A1 receptor |
|
ISO |
|
RGD |
PMID:15630442 |
RGD:5129098 |
NCBI chr 9:113,835,279...113,875,899
Ensembl chr 9:113,835,921...113,872,365
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
associated with Anemia, Sickle Cell associated with Lung Injury |
RGD |
PMID:17601796 PMID:18703794 PMID:20798237 |
RGD:4890358 RGD:4890364 RGD:4890376 |
NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:19925785 |
RGD:4145041 |
NCBI chr 2:150,032,649...150,035,591
Ensembl chr 2:150,033,579...150,040,731
|
|
G |
AGT |
angiotensinogen |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28960804 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G |
AHR |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23337360 |
|
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
|
|
G |
ALB |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:23286966 |
RGD:11035283 |
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:15021973 |
RGD:4891030 |
NCBI chr 7:117,438,622...117,472,005
Ensembl chr 7:117,438,713...117,472,005
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:10886251 |
RGD:5129562 |
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17079327 |
RGD:5129688 |
NCBI chr 5:63,088,778...63,098,750
Ensembl chr 5:63,088,778...63,098,750
|
|
G |
C5 |
complement C5 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:3631740 PMID:17079327 |
RGD:5129688 RGD:5130161 |
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
|
|
G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
|
|
G |
CCL11 |
chemokine (C-C motif) ligand 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung, respiratory system fluid/secretion |
RGD CTD |
PMID:10595930 PMID:11290805 PMID:21625544 |
RGD:4145445 RGD:4145450 |
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung |
CTD RGD |
PMID:15993846 PMID:21625544 |
RGD:2306304 |
NCBI chr 6:19,345,929...19,372,972
Ensembl chr 6:19,345,941...19,348,926
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr10:32,110,366...32,112,529
Ensembl chr10:32,110,065...32,112,734
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19648283 PMID:21625544 |
RGD:4891461 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr15:129,172,743...129,176,069
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chr 6:19,296,726...19,301,506
Ensembl chr 6:19,296,637...19,302,737
|
|
G |
CCL24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 3:10,347,397...10,361,500
|
|
G |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr12:39,479,190...39,480,511
Ensembl chr12:39,478,882...39,481,082
|
|
G |
CCL8 |
chemokine (C-C motif) ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr12:40,740,468...40,741,970
Ensembl chr12:40,740,023...40,742,022
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20870892 PMID:21625544 |
RGD:5688175 |
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14615370 PMID:17284325 PMID:21625544 |
RGD:4145068 RGD:8661704 |
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19762220 |
RGD:4145622 |
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,286,467
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse) |
RGD |
PMID:15546955 |
RGD:4892103 |
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 1:2,016,600...2,034,172
Ensembl chr 1:2,018,608...2,019,821
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:16394278 |
RGD:5130919 |
NCBI chr12:21,857,286...21,869,211
Ensembl chr12:21,857,286...21,872,475
|
|
G |
CCR9 |
C-C motif chemokine receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr13:29,033,609...29,051,227
Ensembl chr13:29,033,570...29,054,598
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
protein:increased expression:multiple |
RGD |
PMID:20302606 |
RGD:4144794 |
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
|
|
G |
CD163 |
CD163 molecule |
|
ISO |
associated with liver disease;protein:increased expression:blood serum (human) |
RGD |
PMID:26339412 |
RGD:11251207 |
NCBI chr 5:63,300,200...63,334,497
Ensembl chr 5:63,300,231...63,334,498
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
|
|
G |
COQ6 |
coenzyme Q6, monooxygenase |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr 7:97,258,617...97,270,927
Ensembl chr 7:97,258,653...97,271,093
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:16855006 |
RGD:5130933 |
NCBI chr18:42,251,755...42,296,457
Ensembl chr18:42,251,749...42,295,467
|
|
G |
CRP |
C-reactive protein, pentraxin-related |
severity disease_progression |
ISO |
|
RGD |
PMID:21258955 PMID:21439658 |
RGD:5131283 RGD:5131291 |
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11732872 PMID:19633061 |
RGD:4142837 |
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 6:92,550,159...92,565,798
Ensembl chr 6:92,550,161...92,565,477
|
|
G |
CSK |
C-terminal Src kinase |
|
ISO |
|
RGD |
PMID:14975240 |
RGD:5134363 |
NCBI chr 7:58,736,473...58,755,034
Ensembl chr 7:58,736,531...58,755,260
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 6:19,312,351...19,324,439
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung |
RGD |
PMID:14979941 PMID:15265940 |
RGD:5135445 RGD:5135491 |
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO |
mRNA:increased expression:lung mRNA, protein:increased expression:lung |
RGD |
PMID:18367723 PMID:20728373 |
RGD:5134959 RGD:5135235 |
NCBI chr 8:70,157,253...70,159,145
Ensembl chr 8:70,157,214...70,159,138
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15265940 PMID:17052299 PMID:21625544 |
RGD:5135440 RGD:5135445 |
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr15:120,219,657...120,230,203
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung |
CTD RGD |
PMID:14979941 PMID:15265940 PMID:21625544 |
RGD:5135445 RGD:5135491 |
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
ISO |
protein:increased expression:alveolus, epithelial cell DNA:polymorphism (human) |
RGD |
PMID:14698565 PMID:15928955 |
RGD:4142512 RGD:4892223 |
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
|
|
G |
DEFB1 |
defensin beta 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17000097 |
RGD:4892262 |
|
|
G |
EDN1 |
endothelin 1 |
severity |
ISO |
protein:increased secretion:plasma (human) |
RGD |
PMID:20529344 |
RGD:4144879 |
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
EGF |
epidermal growth factor |
resistance |
ISO |
|
RGD |
PMID:21701422 |
RGD:6906904 |
NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29787794 |
|
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
|
|
G |
ENTPD5 |
ectonucleoside triphosphate diphosphohydrolase 5 (inactive) |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr 7:97,270,698...97,316,578
Ensembl chr 7:97,266,824...97,306,981
|
|
G |
FCGR3A |
Fc fragment of IgG receptor IIIa |
treatment |
ISO |
associated with Hodgkin Disease;DNA:SNP:exon:p.F158V (rs396991) (human) |
RGD |
PMID:20423913 |
RGD:11352258 |
NCBI chr 4:88,948,357...88,956,513
|
|
G |
GRP |
gastrin releasing peptide |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:30146822 |
RGD:401700396 |
NCBI chr 1:161,708,815...161,721,986
Ensembl chr 1:161,708,812...161,721,782
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:14556983 |
RGD:5143922 |
NCBI chr 1:121,505,677...121,525,416
Ensembl chr 1:121,505,751...121,525,252
|
|
G |
HMOX1 |
heme oxygenase 1 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:allele:promoter:L allele of the (GT)n repeat (>30 repeats) |
CTD RGD |
PMID:16582079 |
RGD:1601608 |
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Reperfusion Injury |
RGD |
PMID:22882462 |
RGD:8547727 |
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
resistance |
ISO |
Cryptococcus (yeast) pneumonia |
RGD |
PMID:18566423 |
RGD:5490275 |
NCBI chr13:196,925,731...196,951,398
Ensembl chr13:196,925,734...196,952,239
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20080200 PMID:31095431 |
RGD:7495767 |
NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
|
|
G |
IL10 |
interleukin 10 |
disease_progression |
ISO |
protein:increased expression:blood |
RGD |
PMID:20595152 |
RGD:4140400 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
associated with Respiratory Distress Syndrome, Newborn; protein:increased expression:bronchoalveolar lavage fluid CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19695190 PMID:21625544 |
RGD:4145774 |
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
mRNA:increased expression:lung, fibroblast |
RGD |
PMID:15161635 |
RGD:4890021 |
NCBI chr X:94,402,665...94,455,609
Ensembl chr X:94,402,676...94,439,060
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20498020 PMID:21625544 PMID:22848348 |
RGD:4888524 RGD:9068417 |
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with reperfusion injury mRNA, protein:increased expression:lung,bronchoalveolar fluid protein:increased expression:serum |
CTD RGD |
PMID:11739527 PMID:15955140 PMID:16052682 PMID:17400729 PMID:21625544 |
RGD:4889590 RGD:4889825 RGD:4889836 RGD:729357 |
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:8806881 |
RGD:7794765 |
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 3:52,192,912...52,334,734
Ensembl chr 3:52,192,915...52,288,485
|
|
G |
IL1R2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr 3:52,367,434...52,406,393
Ensembl chr 3:52,367,437...52,406,334
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
no_association disease_progression |
ISO |
mRNA:increased expression:bronchioalveolar lavage fluid, neutrophil (rat) mRNA:increased expression:bronchoalveolar lavage (human) DNA:polymorphism (human) DNA:polymorphism:intron (human) mRNA:increased expression:lung |
RGD |
PMID:1385928 PMID:16369129 PMID:17569781 PMID:18838927 PMID:19900796 PMID:32407669 More...
|
RGD:30296672 RGD:4142865 RGD:4142871 RGD:4143204 RGD:4143213 RGD:8551846 |
|
|
G |
IL27 |
interleukin 27 |
|
ISO |
|
RGD |
PMID:19124731 |
RGD:5128483 |
NCBI chr 3:18,421,962...18,427,916
Ensembl chr 3:18,421,981...18,427,915
|
|
G |
IL2RB |
interleukin 2 receptor subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 5:10,610,094...10,650,315
Ensembl chr 5:10,628,962...10,650,314
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24453940 |
|
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|
G |
IL4R |
interleukin 4 receptor |
|
| |